Plant-Based protein tested in 2,000 patients with low blood albumin
NCT ID NCT07435922
First seen Mar 06, 2026 · Last updated May 04, 2026 · Updated 11 times
Summary
This study is observing the safety and effectiveness of a plant-based human albumin in about 2,000 patients who urgently need treatment for low blood albumin or low blood volume. Doctors decide whether to use the drug based on standard care, and researchers track side effects and changes in albumin levels. The goal is to gather real-world data on how well this treatment works and how safe it is.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOALBUMINEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hebei medical university third hosipital
Shijiazhuang, Hebei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.